NOV 20, 2019 7:18 PM PST

Mining 'Junk' DNA for New Cancer Therapeutics

WRITTEN BY: Carmen Leitch

There are about 20,000 genes in the human genome that code for proteins, which are essential to the form and function of our physiology. But those coding regions only make up about two percent of the genome. Once dismissed as 'junk,' researchers are now learning more about the vast, noncoding regions of the genome. Researchers have now found new targets for the treatment of cancer within these areas by using cutting edge genomic sequencing techniques, which have helped them learn more about the regulatory purposes they serve. The findings have been reported in Cancer Cell.

Researcher Dr. Mathieu Lupien, Senior Scientist, Princess Margaret Cancer Centre, knew that these non-coding regions served a purpose, and has devoted his work to learn more about them. "We are exploring uncharted territory," Lupien said. "Our goal is to conquer cancer in our lifetime. We have to look everywhere including the darkest parts of the genome of cancer cells for that hidden gold."

Dr. Lupien led an international team of scientists and clinicians in the analysis of 270,000 mutations that were found in primary prostate tumors. The researchers learned that these genetic errors appear in certain noncoding regions that impact proteins that help control whether gene expression is turned on or off. These proteins, dubbed "the maestro of the cell" by Lupien, can stop prostate cancer cells from growing, which makes them good targets for therapeutics.

Image credit: Public Domain Pictures

This opens up new avenues in cancer therapy, and capitalizes on the data gathered from their analysis of the mutations in both coding and noncoding areas, he said. "Just imagine the possibilities the noncoding genome opens up," he continued.

Noncoding regions have been increasingly recognized for their influence on not only gene expression, but also disease. Lupien explained that millions of switches that affect gene expression are contained in these portions of the genome, and can impact different types of cells throughout the body.

"Now we can start connecting these genetic switches to cancer development to get a more precise understanding of how disease begins and how we can treat it," he added.

Expanding what we know about biomarkers can help improve precision medicine, said Lupien. "The inclusion of the noncoding genome in our analysis is a leap in the right direction to achieve our goal," he concluded.

Sources: AAAS/Eurekalert! via University Health Network, Cancer Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 12, 2020
Genetics & Genomics
JAN 12, 2020
Water Lily Genome Provides Insight Into Flowering Plant Evolution
The genomic sequence of an ancient flowering plant, the water lily Nymphaea colorata, has been revealed....
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
How To Choose The Right DNA Testing Kit For You
One of the most exciting scientific advancements in the past decade, at least in terms of its impact on pop culture, was the sudden accessibility of home D...
MAR 22, 2020
Genetics & Genomics
MAR 22, 2020
The Evolutionary Origins of the Human Hand
An ancient fish fossil has given researchers new insight into how fish fins eventually evolved into human hands....
MAR 04, 2020
Neuroscience
MAR 04, 2020
Memories Are Stored As Specific Neural Firing Patterns
Scientists working on the EPFL Blue Brain Project explain the algebraic patterns of neuron activity.  Scientists at the National Institute of Health&r...
MAR 27, 2020
Genetics & Genomics
MAR 27, 2020
Expanding the Genomic Regions That Can Be Targeted With CRISPR
CRISPR gene-editing technology has sparked a revolution in biomedical research and is poised to have far-reaching applications in medicine....
Loading Comments...